Pharmacological modulation of GITRL/GITR system: Therapeutic perspectives

British Journal of Pharmacology

Volumn 165, Issue 7, 2012, Pages 2089-2099

  Nocentini, Giuseppe ^a   Ronchetti, Simona ^a   Petrillo, Maria Grazia ^a   Riccardi, Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

anti infectious treatment; anti inflammatory treatment; anti tumour treatment; antibodies; fusion proteins; human diseases; tumour necrosis factor receptor superfamily

Indexed keywords

CD28 ANTIGEN; DIMER; GAG PROTEIN; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR ANTIBODY; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR G3C ANTIBODY; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN FC FRAGMENT; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; MONOCLONAL ANTIBODY; MONOMER; RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DIMERIZATION; DISEASE MODEL; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER T CELL; NONHUMAN; OLIGOMERIZATION; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR REJECTION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; LIGANDS; MICE; MODELS, IMMUNOLOGICAL; SPECIES SPECIFICITY; T-LYMPHOCYTES; TUMOR NECROSIS FACTORS;

EID: 84858236143     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01753.x     Document Type: Review

References (101)

1. Agostini M, Cenci E, Pericolini E, Nocentini G, Bistoni G, Vecchiarelli A, et al,. (2005). The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection. Infect Immun 73: 7502-7508. (Pubitemid 41587655)
2. Azuma M, (2010). Role of the glucocorticoid-induced TNFR-related protein (GITR)-GITR ligand pathway in innate and adaptive immunity. Crit Rev Immunol 30: 547-557.
3. Bae E, Kim WJ, Kang YM, Suk K, Koh EM, Cha HS, et al,. (2007). Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis. Clin Exp Immunol 148: 410-418. (Pubitemid 46701026)
4. Bae EM, Kim WJ, Suk K, Kang YM, Park JE, Kim WY, et al,. (2008). Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol Immunol 45: 523-533. (Pubitemid 47332628)
5. Baessler T, Krusch M, Schmiedel BJ, Kloss M, Baltz KM, Wacker A, et al,. (2009). Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. Cancer Res 69: 1037-1045.
6. Baltz KM, Krusch M, Bringmann A, Brossart P, Mayer F, Kloss M, et al,. (2007). Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions. FASEB J 21: 2442-2454. (Pubitemid 47230674)
7. Baltz KM, Krusch M, Baessler T, Schmiedel BJ, Bringmann A, Brossart P, et al,. (2008). Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivity. Blood 112: 3735-3743.
8. Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, Sportoletti P, et al,. (2011). CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T cell population with regulatory activity. Eur J Immunol 41: 2269-2278.
9. Boczkowski D, Lee J, Pruitt S, Nair S, (2009). Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy. Cancer Gene Ther 16: 900-911.
10. Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, et al,. (2006). Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem 281: 13964-13971. (Pubitemid 43848322)
11. Bueno LL, Morais CG, Araujo FF, Gomes JA, Correa-Oliveira R, Soares IS, et al,. (2010). Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS ONE 5: e9623.
12. Burckhart T, Thiel M, Nishikawa H, Wuest T, Muller D, Zippelius A, et al,. (2010). Tumor-specific crosslinking of GITR as costimulation for immunotherapy. J Immunother 33: 925-934.
13. Bushell A, Wood K, (2007). GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function. Am J Transplant 7: 759-768. (Pubitemid 46486618)
14. Byrne AM, Goleva E, Leung DY, (2009). Identification of glucocorticoid-induced TNF receptor-related protein ligand on keratinocytes: ligation by GITR induces keratinocyte chemokine production and augments T-cell proliferation. J Invest Dermatol 129: 2784-2794.
15. Cabezon R, Sintes J, Llinas L, Benitez-Ribas D, (2011). Analysis of HLDA9 mAbs on plasmacytoid dendritic cells. Immunol Lett 134: 167-173.
16. Calmels B, Paul S, Futin N, Ledoux C, Stoeckel F, Acres B, (2005). Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L. Cancer Gene Ther 12: 198-205. (Pubitemid 40205100)
17. Cardona ID, Goleva E, Ou LS, Leung DY, (2006). Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol 117: 688-695. (Pubitemid 43340237)
18. Chattopadhyay K, Ramagopal UA, Mukhopadhaya A, Malashkevich VN, Dilorenzo TP, Brenowitz M, et al,. (2007). Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: implications for function. Proc Natl Acad Sci USA 104: 19452-19457.
19. Chattopadhyay K, Ramagopal UA, Brenowitz M, Nathenson SG, Almo SC, (2008). Evolution of GITRL immune function: murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily. Proc Natl Acad Sci U S A 105: 635-640. (Pubitemid 351171760)
20. Chattopadhyay K, Lazar-Molnar E, Yan Q, Rubinstein R, Zhan C, Vigdorovich V, et al,. (2009). Sequence, structure, function, immunity: structural genomics of costimulation. Immunol Rev 229: 356-386.
21. Chen S, Ndhlovu LC, Takahashi T, Takeda K, Ikarashi Y, Kikuchi T, et al,. (2008). Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells. Eur J Immunol 38: 2229-2240.
22. Cho JS, Hsu JV, Morrison SL, (2009). Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity. Cancer Immunol Immunother 58: 1057-1069.
23. Coe D, Begom S, Addey C, White M, Dyson J, Chai JG, (2010). Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunol Immunother 59: 1367-1377.
24. Cohen AD, Schaer DA, Liu C, Li Y, Hirschhorn-Cymmerman D, Kim SC, et al,. (2010). Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation. PLoS ONE 5: e10436.
25. Condomines M, Quittet P, Lu ZY, Nadal L, Latry P, Lopez E, et al,. (2006). Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol 176: 6631-6639. (Pubitemid 43787846)
26. Cosmi L, Liotta F, Lazzeri E, Francalanci M, Angeli R, Mazzinghi B, et al,. (2003). Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102: 4107-4114. (Pubitemid 37486995)
27. Cui D, Wang S, Chen Y, Tong J, Ma J, Tang L, et al,. (2010). An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand. Cell Mol Immunol 7: 316-322.
28. Cuzzocrea S, Nocentini G, Di Paola R, Mazzon E, Ronchetti S, Genovese T, et al,. (2004). Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. J Leukoc Biol 76: 933-940. (Pubitemid 39458705)
29. Cuzzocrea S, Ayroldi E, Di Paola R, Agostini M, Mazzon E, Bruscoli S, et al,. (2005). Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB J 19: 1253-1265. (Pubitemid 41113722)
30. Cuzzocrea S, Nocentini G, Di Paola R, Agostini M, Mazzon E, Ronchetti S, et al,. (2006). Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. J Immunol 177: 631-641. (Pubitemid 43939177)
31. Cuzzocrea S, Ronchetti S, Genovese T, Mazzon E, Agostini M, Di Paola R, et al,. (2007). Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB J 21: 117-129. (Pubitemid 46052551)
32. Dittmer U, Werner T, Kraft AR, (2008). Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection. Viral Immunol 21: 459-467.
33. Esparza EM, Arch RH, (2005). Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation. J Immunol 174: 7875-7882. (Pubitemid 40806297)
34. Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L, et al,. (2011a). GITR gene deletion and GITR-Fc soluble protein administration inhibit multiple organ failure induced by zymosan. Shock 36: 263-271.
35. Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L, et al,. (2011b). The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice. Br J Pharmacol 162: 1186-1201.
36. Gerli R, Nocentini G, Alunno A, Bocci EB, Bianchini R, Bistoni O, et al,. (2009). Identification of regulatory T cells in systemic lupus erythematosus. Autoimmun Rev 8: 426-430.
37. Grohmann U, Volpi C, Fallarino F, Bozza S, Bianchi R, Vacca C, et al,. (2007). Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13: 579-586. (Pubitemid 46828479)
38. Grosser M, Magdolen V, Baretton G, Luther T, Albrecht S, (2011). Gene expression analysis of HUVEC in response to TF-binding. Thromb Res 127: 259-263.
39. Gurney AL, Marsters SA, Huang RM, Pitti RM, Mark DT, Baldwin DT, et al,. (1999). Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol 9: 215-218. (Pubitemid 29120387)
40. Haque A, Stanley AC, Amante FH, Rivera Fde L, Zhou Y, Kuns RD, et al,. (2010). Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. J Immunol 184: 2583-2592.
41. Heikkinen J, Mottonen M, Alanen A, Lassila O, (2004). Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 136: 373-378. (Pubitemid 38543459)
42. Hori J, Taniguchi H, Wang M, Oshima M, Azuma M, (2010). GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts. Invest Ophthalmol Vis Sic 51: 6556-6565.
43. Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, et al,. (2008). Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Clin Cancer Res 14: 579-588. (Pubitemid 351226128)
44. Kamimura Y, Iwai H, Piao J, Hashiguchi M, Azuma M, (2009). The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. J Immunol 182: 2708-2716.
45. Kim JI, Sonawane SB, Lee MK, Lee SH, Duff PE, Moore DJ, et al,. (2010). Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. Eur J Immunol 40: 1369-1374.
46. Kim YS, Jung HW, Choi J, Kwon BS, Ham SY, Jung AK, et al,. (2007). Expression of AITR and AITR ligand in breast cancer patients. Oncol Rep 18: 1189-1194.
47. Kober J, Leitner J, Klauser C, Woitek R, Majdic O, Stockl J, et al,. (2008). The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol 38: 2678-2688.
48. Kohm AP, Williams JS, Miller SD, (2004). Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J Immunol 172: 4686-4690. (Pubitemid 38456388)
49. Krausz LT, Bianchini R, Ronchetti S, Fettucciari K, Nocentini G, Riccardi C, (2007). GITR-GITRL system, a novel player in shock and inflammation. ScientificWorldJournal 7: 533-566.
50. Kwon B, Yu KY, Ni J, Yu GL, Jang IK, Kim YJ, et al,. (1999). Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem 274: 6056-6061. (Pubitemid 29111009)
51. Kwon B, Kim BS, Cho HR, Park JE, Kwon BS, (2003). Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases. Exp Mol Med 35: 8-16. (Pubitemid 36336923)
52. Lau KM, Cheng SH, Lo KW, Lee SA, Woo JK, Van Hasselt CA, et al,. (2007). Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer 96: 617-622.
53. Lee SK, Choi BK, Kim YH, Kang WJ, Kim KH, Sakaguchi S, et al,. (2006). Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells. Immunology 119: 479-487. (Pubitemid 44722210)
54. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC, et al,. (2002). Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 196: 1335-1346. (Pubitemid 35375552)
55. Liao G, Nayak S, Regueiro JR, Berger SB, Detre C, Romero X, et al,. (2010). GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int Immunol 22: 259-270.
56. Liu B, Li Z, Mahesh SP, Pantanelli S, Hwang FS, Siu WO, et al,. (2008). Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis. J Biol Chem 283: 8202-8210.
57. Mahesh SP, Li Z, Liu B, Fariss RN, Nussenblatt RB, (2006). Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines. Eur J Immunol 36: 2128-2138. (Pubitemid 44251758)
58. Mahic M, Henjum K, Yaqub S, Bjornbeth BA, Torgersen KM, Tasken K, et al,. (2008). Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 38: 640-646.
59. Masuda M, Matsumoto M, Tanaka S, Nakajima K, Yamada N, Ido N, et al,. (2010). Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol 225: 123-131.
60. Matesanz-Isabel J, Sintes J, Llinas L, de Salort J, Lazaro A, Engel P, (2011). New B-cell CD molecules. Immunol Lett 134: 104-112.
61. Morris GP, Kong YC, (2006). Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 26: 24-31. (Pubitemid 43138889)
62. Murciano C, Villamon E, O'Connor JE, Gozalbo D, Gil ML, (2006). Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect Immun 74: 1403-1406. (Pubitemid 43185583)
63. Nishioka T, Nishida E, Iida R, Morita A, Shimizu J, (2008). In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules. Immunol Lett 121: 97-104.
64. Nocentini G, Riccardi C, (2009). GITR: a modulator of immune response and inflammation. Adv Exp Med Biol 647: 156-173.
65. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R, et al,. (1997). A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci U S A 94: 6216-6221. (Pubitemid 27270664)
66. Nocentini G, Cuzzocrea S, Genovese T, Bianchini R, Mazzon E, Ronchetti S, et al,. (2008). Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury. Mol Pharmacol 73: 1610-1621. (Pubitemid 351724350)
67. O'Keeffe GW, Gutierrez H, Pandolfi PP, Riccardi C, Davies AM, (2008). NGF-promoted axon growth and target innervation requires GITRL-GITR signaling. Nat Neurosci 11: 135-142. (Pubitemid 351170494)
68. Van Olffen RW, Koning N, Van Gisbergen KP, Wensveen FM, Hoek RM, Boon L, et al,. (2009). GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J Immunol 182: 7490-7500.
69. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, et al,. (2005). Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. Eur J Immunol 35: 3581-3590. (Pubitemid 43025538)
70. Perez Novo CA, Jedrzejczak-Czechowicz M, Lewandowska-Polak A, Claeys C, Holtappels G, Van Cauwenberge P, et al,. (2010). T cell inflammatory response, Foxp3 and TNFRS18-L regulation of peripheral blood mononuclear cells from patients with nasal polyps-asthma after staphylococcal superantigen stimulation. Clin Exp Allergy 40: 1323-1332.
71. Piao J, Kamimura Y, Iwai H, Cao Y, Kikuchi K, Hashiguchi M, et al,. (2009). Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours. Immunology 127: 489-499.
72. Placke T, Kopp HG, Salih HR, (2010). Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation. Clin Dev Immunol doi:10.1155/2010/239083.
73. Ponte J, Doty D, Christmas R, Ponath P, Vaickus L, Rosenzweig M, (2010a). Effect of the antimouse GITR mab plus chemotherapy on survival and tumor immunity. J Clin Oncol 28: e13147.
74. Ponte JF, Ponath P, Gulati R, Slavonic M, Paglia M, O'Shea A, et al,. (2010b). Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody. Immunology 130: 231-242.
75. Poulton LD, Nolan KF, Anastasaki C, Waldmann H, Patton EE, (2010). A novel role for Glucocorticoid-Induced TNF Receptor Ligand (Gitrl) in early embryonic zebrafish development. Int J Dev Biol 54: 815-825.
76. Ramirez-Montagut T, Chow A, Hirschhorn-Cymerman D, Terwey TH, Kochman AA, Lu S, et al,. (2006). Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J Immunol 176: 6434-6442. (Pubitemid 43787825)
77. Ronchetti S, Nocentini G, Riccardi C, Pandolfi PP, (2002). Role of GITR in activation response of T lymphocytes. Blood 100: 350-352. (Pubitemid 35177469)
78. Ronchetti S, Nocentini G, Bianchini R, Krausz LT, Migliorati G, Riccardi C, (2007). Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells. J Immunol 179: 5916-5926.
79. Ronchetti S, Nocentini G, Petrillo MG, Bianchini R, Sportoletti P, Bastianelli A, et al,. (2011). Glucocorticoid-Induced TNFR family Related gene (GITR) enhances dendritic cell activity. Immunol Lett 135: 24-33.
80. Rosenzweig M, Ponte J, Apostolou I, Doty D, Guild J, Slavonic M, et al,. (2010). Development of TRX518, an aglycosyl humanized monoclonal antibody (Mab) agonist of huGITR. J Clin Oncol 28: abstract e13028.
81. Santucci L, Agostini M, Bruscoli S, Mencarelli A, Ronchetti S, Ayroldi E, et al,. (2007). GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 56: 52-60. (Pubitemid 46044889)
82. Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, et al,. (2008). Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 38: 3101-3113.
83. Schaer DA, Cohen AD, Wolchok JD, (2010). Anti-GITR antibodies-potential clinical applications for tumor immunotherapy. Curr Opin Investig Drugs 11: 1378-1386.
84. Scotto L, Naiyer AJ, Galluzzo S, Rossi P, Manavalan JS, Kim-Schulze S, et al,. (2004). Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum Immunol 65: 1297-1306. (Pubitemid 39535293)
85. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S, (2002). Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3: 135-142. (Pubitemid 34141443)
86. Shin HH, Kim SJ, Lee DS, Choi HS, (2005). Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-kappaB ligand (RANKL) in osteoclast cells. Bone 36: 832-839.
87. Snell LM, McPherson AJ, Lin GH, Sakaguchi S, Pandolfi PP, Riccardi C, et al,. (2010). CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. J Immunol 185: 7223-7234.
88. Sonawane SB, Kim JI, Lee MK, Lee SH, Duff PE, Moore DJ, et al,. (2009). GITR blockade facilitates treg mediated allograft survival. Transplantation 88: 1169-1177.
89. Spinicelli S, Nocentini G, Ronchetti S, Krausz LT, Bianchini R, Riccardi C, (2002). GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death Differ 9: 1382-1384. (Pubitemid 36097709)
90. Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, et al,. (2004). Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173: 5008-5020. (Pubitemid 39387783)
91. Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, et al,. (2006a). Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol 80: 1762-1772. (Pubitemid 43228717)
92. Stone GW, Barzee S, Snarsky V, Spina CA, Lifson JD, Pillai VK, et al,. (2006b). Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro. Clin Vaccine Immunol 13: 1223-1230. (Pubitemid 46768880)
93. Suri A, Shimizu J, Katz JD, Sakaguchi S, Unanue ER, Kanagawa O, (2004). Regulation of autoimmune diabetes by non-islet-specific T cells-a role for the glucocorticoid-induced TNF receptor. Eur J Immunol 34: 447-454. (Pubitemid 39255955)
94. Tone M, Tone Y, Adams E, Yates SF, Frewin MR, Cobbold SP, et al,. (2003). Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA 100: 15059-15064. (Pubitemid 37518016)
95. Tuyaerts S, Van Meirvenne S, Bonehill A, Heirman C, Corthals J, Waldmann H, et al,. (2007). Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells. J Leukoc Biol 82: 93-105. (Pubitemid 47026420)
96. Wang J, Devgan V, Corrado M, Prabhu NS, El-Deiry WS, Riccardi C, et al,. (2005). Glucocorticoid-induced tumor necrosis factor receptor is a p21Cip1/WAF1 transcriptional target conferring resistance of keratinocytes to UV light-induced apoptosis. J Biol Chem 280: 37725-37731. (Pubitemid 41642381)
97. Wyzgol A, Muller N, Fick A, Munkel S, Grigoleit GU, Pfizenmaier K, et al,. (2009). Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. J Immunol 183: 1851-1861.
98. You S, Poulton L, Cobbold S, Liu CP, Rosenzweig M, Ringler D, et al,. (2009). Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target. PLoS ONE 4: e7848.
99. Zhou P, Qiu J, L'Italien L, Gu D, Hodges D, Chao CC, et al,. (2010). Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody. J Immunother 33: 789-797.
100. Zhou Z, Song X, Berezov A, Zhang G, Li Y, Zhang H, et al,. (2008a). Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states. Proc Natl Acad Sci USA 105: 5465-5470. (Pubitemid 351753886)
101. Zhou Z, Tone Y, Song X, Furuuchi K, Lear JD, Waldmann H, et al,. (2008b). Structural basis for ligand-mediated mouse GITR activation. Proc Natl Acad Sci USA 105: 641-645. (Pubitemid 351171761)